메뉴 건너뛰기




Volumn 58, Issue 3, 2009, Pages 452-463

Immunosuppression for liver transplantation

Author keywords

[No Author keywords available]

Indexed keywords

4 [N [1 (2 CYANO 1 OXOETHYL) 4 METHYL 3 PIPERIDINYL] N METHYLAMINO]PYRROLO[2,3 D]PYRIMIDINE; ALEMTUZUMAB; ARACHIDONIC ACID; AZATHIOPRINE; B7 ANTIGEN; BASILIXIMAB; BELATACEPT; CALCINEURIN INHIBITOR; CD86 ANTIGEN; CORTICOSTEROID; CYCLOPHILIN; CYCLOSPORIN; DACLIZUMAB; EFALIZUMAB; EVEROLIMUS; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 2 RECEPTOR ANTIBODY; MAJOR HISTOCOMPATIBILITY ANTIGEN; MAMMALIAN TARGET OF RAPAMYCIN INHIBITOR; METHYLPREDNISOLONE; MYCOPHENOLIC ACID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RAPAMYCIN; SOTRASTAURIN; STEROID; TACROLIMUS; THYMOCYTE ANTIBODY; TRANSCRIPTION FACTOR NFAT; TRANSFORMING GROWTH FACTOR BETA; UNINDEXED DRUG;

EID: 61649104846     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gut.2008.163527     Document Type: Review
Times cited : (107)

References (105)
  • 1
    • 0028966356 scopus 로고
    • Combined transplantation of liver and kidney from the same donor protects the kidney from rejection and improves kidney graft survival
    • Rasmussen A, Davies HF, Jamieson NV, et al. Combined transplantation of liver and kidney from the same donor protects the kidney from rejection and improves kidney graft survival. Transplantation 1995;59:919-21.
    • (1995) Transplantation , vol.59 , pp. 919-921
    • Rasmussen, A.1    Davies, H.F.2    Jamieson, N.V.3
  • 2
    • 33747489301 scopus 로고    scopus 로고
    • Combined lung and liver transplantation: The United States experience
    • Kotru A, Sheperd R, Nadler M, et al. Combined lung and liver transplantation: the United States experience. Transplantation 2006;82:144-5.
    • (2006) Transplantation , vol.82 , pp. 144-145
    • Kotru, A.1    Sheperd, R.2    Nadler, M.3
  • 3
    • 0019796723 scopus 로고
    • Reversal of transplantation immunity by liver grafting
    • Kamada N, Davies HS, Roser B. Reversal of transplantation immunity by liver grafting. Nature 1981;292:840-3.
    • (1981) Nature , vol.292 , pp. 840-843
    • Kamada, N.1    Davies, H.S.2    Roser, B.3
  • 4
    • 33645554690 scopus 로고    scopus 로고
    • The effect of HLA class I (A and B) and class II (DR) compatibility on liver transplantation outcomes: An analysis of the OPTN database
    • Navarro V, Herrine S, Katopes C, et al. The effect of HLA class I (A and B) and class II (DR) compatibility on liver transplantation outcomes: an analysis of the OPTN database. Liver Transpl 2006;12:652-8.
    • (2006) Liver Transpl , vol.12 , pp. 652-658
    • Navarro, V.1    Herrine, S.2    Katopes, C.3
  • 5
    • 30444443316 scopus 로고    scopus 로고
    • The effect of HLA mismatches, shared cross-reactive antigen groups, and shared HLA-DR antigens on the outcome after pediatric liver transplantation
    • Sieders E, Hepkema BG, Peeters PM, et al. The effect of HLA mismatches, shared cross-reactive antigen groups, and shared HLA-DR antigens on the outcome after pediatric liver transplantation. Liver Transpl 2005;11:1541-9.
    • (2005) Liver Transpl , vol.11 , pp. 1541-1549
    • Sieders, E.1    Hepkema, B.G.2    Peeters, P.M.3
  • 6
    • 0001315607 scopus 로고
    • Successful sequential liver-kidney transplantation in patients with performed lymphocytotoxic antibodies
    • Fung JJ, Makowka L, Griffin M, et al. Successful sequential liver-kidney transplantation in patients with performed lymphocytotoxic antibodies. Clin Transplant 1987;1:187-94.
    • (1987) Clin Transplant , vol.1 , pp. 187-194
    • Fung, J.J.1    Makowka, L.2    Griffin, M.3
  • 7
    • 0014661390 scopus 로고
    • Induction of immunological tolerance by porcine liver allografts
    • Calne RY, Sells RA, Pena JR, et al. Induction of immunological tolerance by porcine liver allografts. Nature 1969;223:472-6.
    • (1969) Nature , vol.223 , pp. 472-476
    • Calne, R.Y.1    Sells, R.A.2    Pena, J.R.3
  • 8
    • 33846928735 scopus 로고    scopus 로고
    • Operational tolerance in clinical liver transplantation: Emerging developments
    • Tisone G, Orlando G, Angelico M. Operational tolerance in clinical liver transplantation: emerging developments. Transpl Immunol 2007;17:108-13.
    • (2007) Transpl Immunol , vol.17 , pp. 108-113
    • Tisone, G.1    Orlando, G.2    Angelico, M.3
  • 9
    • 0005984244 scopus 로고
    • Actively acquired tolerance of foreign cells
    • Billingham RE, Brent L, Medawar PB. Actively acquired tolerance of foreign cells. Nature 1953;172:603-6.
    • (1953) Nature , vol.172 , pp. 603-606
    • Billingham, R.E.1    Brent, L.2    Medawar, P.B.3
  • 10
    • 38549134052 scopus 로고    scopus 로고
    • Tolerance and chimerism after renal and hematopoietic-cell transplantation
    • Scandling JD, Busque S, Dejbakhsh-Jones S, et al. Tolerance and chimerism after renal and hematopoietic-cell transplantation. N Engl J Med 2008;358:362-8.
    • (2008) N Engl J Med , vol.358 , pp. 362-368
    • Scandling, J.D.1    Busque, S.2    Dejbakhsh-Jones, S.3
  • 11
    • 38549155221 scopus 로고    scopus 로고
    • Chimerism and tolerance in a recipient of a deceased-donor liver transplant
    • Alexander SI, Smith N, Hu M, et al. Chimerism and tolerance in a recipient of a deceased-donor liver transplant. N Engl J Med 2008;358:369-74.
    • (2008) N Engl J Med , vol.358 , pp. 369-374
    • Alexander, S.I.1    Smith, N.2    Hu, M.3
  • 12
    • 38549088096 scopus 로고    scopus 로고
    • HLA-mismatched renal transplantation without maintenance immunosuppression
    • Kawai T, Cosimi AB, Spitzer TR, et al. HLA-mismatched renal transplantation without maintenance immunosuppression. N Engl J Med 2008;358:353-61.
    • (2008) N Engl J Med , vol.358 , pp. 353-361
    • Kawai, T.1    Cosimi, A.B.2    Spitzer, T.R.3
  • 13
    • 3843066657 scopus 로고    scopus 로고
    • Natural history of hepatitis C following liver transplantation
    • Rodriguez-Luna H, Douglas DD. Natural history of hepatitis C following liver transplantation. Curr Opin Infect Dis 2004;17:363-71.
    • (2004) Curr Opin Infect Dis , vol.17 , pp. 363-371
    • Rodriguez-Luna, H.1    Douglas, D.D.2
  • 14
    • 33845489455 scopus 로고    scopus 로고
    • Recurrence of autoimmune liver disease after liver transplantation: A systematic review
    • Gautam M, Cheruvattath R, Balan V. Recurrence of autoimmune liver disease after liver transplantation: a systematic review. Liver Transpl 2006;12:1813-24.
    • (2006) Liver Transpl , vol.12 , pp. 1813-1824
    • Gautam, M.1    Cheruvattath, R.2    Balan, V.3
  • 15
    • 40649112628 scopus 로고    scopus 로고
    • Therapeutic management of posttransplant diabetes mellitus
    • Mannon RB. Therapeutic management of posttransplant diabetes mellitus. Transplant Rev 2008;22:116-24.
    • (2008) Transplant Rev , vol.22 , pp. 116-124
    • Mannon, R.B.1
  • 16
    • 55049119653 scopus 로고    scopus 로고
    • Post-transplant diabetes mellitus in liver transplantation: Hangzhou experience
    • Xu X, Ling Q, He ZL, et al. Post-transplant diabetes mellitus in liver transplantation: Hangzhou experience. Hepatobiliary Pancreat Dis Int 2008;7:465-70.
    • (2008) Hepatobiliary Pancreat Dis Int , vol.7 , pp. 465-470
    • Xu, X.1    Ling, Q.2    He, Z.L.3
  • 17
    • 0017157814 scopus 로고
    • Biological effects of cyclosporin A: A new antilymphocytic agent
    • Borel JF, Feurer C, Gubler HU, et al. Biological effects of cyclosporin A: a new antilymphocytic agent. Agents Actions 1976;6:468-75.
    • (1976) Agents Actions , vol.6 , pp. 468-475
    • Borel, J.F.1    Feurer, C.2    Gubler, H.U.3
  • 18
    • 0018186018 scopus 로고
    • Cyclosporin A in patients receiving renal allografts from cadaver donors
    • Calne RY, White DJ, Thiru S, et al. Cyclosporin A in patients receiving renal allografts from cadaver donors. Lancet 1978;2:1323-7.
    • (1978) Lancet , vol.2 , pp. 1323-1327
    • Calne, R.Y.1    White, D.J.2    Thiru, S.3
  • 19
    • 0003084993 scopus 로고    scopus 로고
    • The mode of action of Prograf (tacrolimus) and its significance for long-term graft survival
    • Hutchinson IV. The mode of action of Prograf (tacrolimus) and its significance for long-term graft survival. New Horizons Kidney Transplantation 1997 1997;1:22-6.
    • (1997) New Horizons Kidney Transplantation , vol.1997 , Issue.1 , pp. 22-26
    • Hutchinson, I.V.1
  • 21
    • 0042360213 scopus 로고    scopus 로고
    • Chronic renal failure after transplantation of a nonrenal organ
    • Ojo AO, Held PJ, Port FK, et al. Chronic renal failure after transplantation of a nonrenal organ. N Engl J Med 2003;349:931-40.
    • (2003) N Engl J Med , vol.349 , pp. 931-940
    • Ojo, A.O.1    Held, P.J.2    Port, F.K.3
  • 22
    • 34548812349 scopus 로고    scopus 로고
    • Therapeutic monitoring of calcineurin inhibitors for the nephrologist
    • Schiff J, Cole E, Cantarovich M. Therapeutic monitoring of calcineurin inhibitors for the nephrologist. Clin J Am Soc Nephrol 2007;2:374-84.
    • (2007) Clin J Am Soc Nephrol , vol.2 , pp. 374-384
    • Schiff, J.1    Cole, E.2    Cantarovich, M.3
  • 23
    • 33645106470 scopus 로고    scopus 로고
    • Cyclosporine suppresses hepatitis C virus in vitro and increases the chance of a sustained virological response after liver transplantation
    • Firpi RJ, Zhu H, Morelli G, et al. Cyclosporine suppresses hepatitis C virus in vitro and increases the chance of a sustained virological response after liver transplantation. Liver Transpl 2006;12:51-7.
    • (2006) Liver Transpl , vol.12 , pp. 51-57
    • Firpi, R.J.1    Zhu, H.2    Morelli, G.3
  • 24
    • 33750713365 scopus 로고    scopus 로고
    • Mycophenolic acid inhibits hepatitis C virus replication and acts in synergy with cyclosporin A and interferon-alpha
    • Henry SD, Metselaar HJ, Lonsdale RC, et al. Mycophenolic acid inhibits hepatitis C virus replication and acts in synergy with cyclosporin A and interferon-alpha. Gastroenterology 2006;131:1452-62.
    • (2006) Gastroenterology , vol.131 , pp. 1452-1462
    • Henry, S.D.1    Metselaar, H.J.2    Lonsdale, R.C.3
  • 25
    • 0142182744 scopus 로고    scopus 로고
    • Cyclosporin A suppresses replication of hepatitis C virus genome in cultured hepatocytes
    • Watashi K, Hijikata M, Hosaka M, et al. Cyclosporin A suppresses replication of hepatitis C virus genome in cultured hepatocytes. Hepatology 2003;38:1282-8.
    • (2003) Hepatology , vol.38 , pp. 1282-1288
    • Watashi, K.1    Hijikata, M.2    Hosaka, M.3
  • 26
    • 33846238124 scopus 로고    scopus 로고
    • Immunosuppression with calcineurin inhibitors with respect to the outcome of HCV recurrence after liver transplantation: Results of a meta-analysis
    • Berenguer M, Royuela A, Zamora J. Immunosuppression with calcineurin inhibitors with respect to the outcome of HCV recurrence after liver transplantation: results of a meta-analysis. Liver Transpl 2007;13:21-9.
    • (2007) Liver Transpl , vol.13 , pp. 21-29
    • Berenguer, M.1    Royuela, A.2    Zamora, J.3
  • 27
    • 0033545299 scopus 로고    scopus 로고
    • Cyclosporine induces cancer progression by a cell-autonomous mechanism
    • Hojo M, Morimoto T, Maluccio M, et al. Cyclosporine induces cancer progression by a cell-autonomous mechanism. Nature 1999;397:530-4.
    • (1999) Nature , vol.397 , pp. 530-534
    • Hojo, M.1    Morimoto, T.2    Maluccio, M.3
  • 28
    • 0036174289 scopus 로고    scopus 로고
    • Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: Involvement of vascular endothelial growth factor
    • Guba M, von Breitenbuch P, Steinbauer M, et al. Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor. Nat Med 2002;8:128-35.
    • (2002) Nat Med , vol.8 , pp. 128-135
    • Guba, M.1    von Breitenbuch, P.2    Steinbauer, M.3
  • 29
    • 2442668989 scopus 로고    scopus 로고
    • Rapamycin protects allografts from rejection while simultaneously attacking tumors in immunosuppressed mice
    • Koehl G, Andrassy J, Guba M, et al. Rapamycin protects allografts from rejection while simultaneously attacking tumors in immunosuppressed mice. Transplantation 2004;77:1319-26.
    • (2004) Transplantation , vol.77 , pp. 1319-1326
    • Koehl, G.1    Andrassy, J.2    Guba, M.3
  • 30
    • 0003188476 scopus 로고
    • Sperimentate su culture pure di bacilli del carbonchio demonstrarano notevole potere antisettica.
    • Gosio B. Sperimentate su culture pure di bacilli del carbonchio demonstrarano notevole potere antisettica. C R Acad Med Torino 1893;61:484.
    • (1893) C R Acad Med Torino , vol.61 , pp. 484
    • Gosio, B.1
  • 31
    • 0014546166 scopus 로고
    • The inhibition of nucleic acid synthesis by mycophenolic acid
    • Franklin TJ, Cook JM. The inhibition of nucleic acid synthesis by mycophenolic acid. Biochem J 1969;113:515-24.
    • (1969) Biochem J , vol.113 , pp. 515-524
    • Franklin, T.J.1    Cook, J.M.2
  • 32
    • 0029115531 scopus 로고    scopus 로고
    • Sollinger HW. Mycophenolate mofetil for the prevention of acute rejection in primary cadaveric renal allograft recipients. U.S. Renal Transplant Mycophenolate Mofetil Study Group. Transplantation 1995;60:225- 32.
    • Sollinger HW. Mycophenolate mofetil for the prevention of acute rejection in primary cadaveric renal allograft recipients. U.S. Renal Transplant Mycophenolate Mofetil Study Group. Transplantation 1995;60:225- 32.
  • 33
    • 0034093785 scopus 로고    scopus 로고
    • Intravenous mycophenolate mofetil: Safety, tolerability, and pharmacokinetics
    • Pescovitz MD, Conti D, Dunn J, et al. Intravenous mycophenolate mofetil: safety, tolerability, and pharmacokinetics. Clin Transplant 2000;14:179-88.
    • (2000) Clin Transplant , vol.14 , pp. 179-188
    • Pescovitz, M.D.1    Conti, D.2    Dunn, J.3
  • 34
    • 34249075713 scopus 로고    scopus 로고
    • MMF to EC-MPS conversion: What makes the difference?
    • Schmidt H, Brockmann J. MMF to EC-MPS conversion: what makes the difference? Liver Transpl 2007;13:773-4.
    • (2007) Liver Transpl , vol.13 , pp. 773-774
    • Schmidt, H.1    Brockmann, J.2
  • 35
    • 0035941732 scopus 로고    scopus 로고
    • Replacement of calcineurin inhibitors with mycophenolate mofetil in liver-transplant patients with renal dysfunction: A randomised controlled study
    • Schlitt HJ, Barkmann A, Böker KHW, et al. Replacement of calcineurin inhibitors with mycophenolate mofetil in liver-transplant patients with renal dysfunction: a randomised controlled study. Lancet 2001;357:587-91.
    • (2001) Lancet , vol.357 , pp. 587-591
    • Schlitt, H.J.1    Barkmann, A.2    Böker, K.H.W.3
  • 36
    • 0035941756 scopus 로고    scopus 로고
    • Mycophenolate mofetil monotherapy in liver transplantation
    • Stewart SF, Hudson M, Talbot D, et al. Mycophenolate mofetil monotherapy in liver transplantation. Lancet 2001;357:609- 10.
    • (2001) Lancet , vol.357 , pp. 609-610
    • Stewart, S.F.1    Hudson, M.2    Talbot, D.3
  • 37
    • 0032573724 scopus 로고    scopus 로고
    • A prospective randomized trial of mycophenolate mofetil with neoral or tacrolimus after orthotopic liver transplantation
    • Fisher RA, Ham JM, Marcos A, et al. A prospective randomized trial of mycophenolate mofetil with neoral or tacrolimus after orthotopic liver transplantation. Transplantation 1998;66:1616-21.
    • (1998) Transplantation , vol.66 , pp. 1616-1621
    • Fisher, R.A.1    Ham, J.M.2    Marcos, A.3
  • 38
    • 0034657919 scopus 로고    scopus 로고
    • Improvement of acute and chronic renal dysfunction in liver transplant patients after substitution of calcineurin inhibitors by mycophenolate mofetil
    • Barkmann A, Nashan B, Schmidt HH, et al. Improvement of acute and chronic renal dysfunction in liver transplant patients after substitution of calcineurin inhibitors by mycophenolate mofetil. Transplantation 2000;69:1886-90.
    • (2000) Transplantation , vol.69 , pp. 1886-1890
    • Barkmann, A.1    Nashan, B.2    Schmidt, H.H.3
  • 39
    • 49649087943 scopus 로고    scopus 로고
    • Monitoring mycophenolic acid pharmacokinetic parameters in liver transplant recipients: Prediction of occurrence of leukopenia
    • Hao C, Anwei M, Bing C, et al. Monitoring mycophenolic acid pharmacokinetic parameters in liver transplant recipients: prediction of occurrence of leukopenia. Liver Transpl 2008;14:1165-73.
    • (2008) Liver Transpl , vol.14 , pp. 1165-1173
    • Hao, C.1    Anwei, M.2    Bing, C.3
  • 40
    • 37549061407 scopus 로고    scopus 로고
    • Validation of limited sampling strategy for the estimation of mycophenolic acid exposure in Chinese adult liver transplant recipients
    • Hao C, Erzheng C, Anwei M, et al. Validation of limited sampling strategy for the estimation of mycophenolic acid exposure in Chinese adult liver transplant recipients. Liver Transpl 2007;13:1684-93.
    • (2007) Liver Transpl , vol.13 , pp. 1684-1693
    • Hao, C.1    Erzheng, C.2    Anwei, M.3
  • 41
    • 1442311438 scopus 로고    scopus 로고
    • Effect of antimetabolite immunosuppressants on Flaviviridae, including hepatitis C virus
    • Stangl JR, Carroll KL, Illichmann M, et al. Effect of antimetabolite immunosuppressants on Flaviviridae, including hepatitis C virus. Transplantation 2004;77:562-7.
    • (2004) Transplantation , vol.77 , pp. 562-567
    • Stangl, J.R.1    Carroll, K.L.2    Illichmann, M.3
  • 42
    • 34548709168 scopus 로고    scopus 로고
    • Differential effects of prednisolone and azathioprine on the development of human cytomegalovirus replication post liver transplantation
    • Nebbia G, Mattes FM, Sabin CA, et al. Differential effects of prednisolone and azathioprine on the development of human cytomegalovirus replication post liver transplantation. Transplantation 2007;84:605-10.
    • (2007) Transplantation , vol.84 , pp. 605-610
    • Nebbia, G.1    Mattes, F.M.2    Sabin, C.A.3
  • 43
    • 3042771789 scopus 로고    scopus 로고
    • A prospective cross-over study comparing the effect of mycophenolate versus azathioprine on allograft function and viral load in liver transplant recipients with recurrent chronic HCV infection
    • Zekry A, Gleeson M, Guney S, et al. A prospective cross-over study comparing the effect of mycophenolate versus azathioprine on allograft function and viral load in liver transplant recipients with recurrent chronic HCV infection. Liver Transpl 2004;10:52-7.
    • (2004) Liver Transpl , vol.10 , pp. 52-57
    • Zekry, A.1    Gleeson, M.2    Guney, S.3
  • 44
    • 0038299000 scopus 로고    scopus 로고
    • Sirolimus: Its discovery, biological properties, and mechanism of action
    • Sehgal SN. Sirolimus: its discovery, biological properties, and mechanism of action. Transplant Proc 2003;35:7S-14S.
    • (2003) Transplant Proc , vol.35
    • Sehgal, S.N.1
  • 45
    • 0142155129 scopus 로고    scopus 로고
    • Renal function improves in liver transplant recipients when switched from a calcineurin inhibitor to sirolimus
    • Fairbanks KD, Eustace JA, Fine D, et al. Renal function improves in liver transplant recipients when switched from a calcineurin inhibitor to sirolimus. Liver Transplantation 2003;9:1079-85.
    • (2003) Liver Transplantation , vol.9 , pp. 1079-1085
    • Fairbanks, K.D.1    Eustace, J.A.2    Fine, D.3
  • 46
    • 34547851713 scopus 로고    scopus 로고
    • Influence of sirolimus on proteinuria in de novo kidney transplantation with expanded criteria donors: Comparison of two CNI-free protocols
    • Diekmann F, Gutierrez-Dalmau A, Lopez S, et al. Influence of sirolimus on proteinuria in de novo kidney transplantation with expanded criteria donors: comparison of two CNI-free protocols. Nephrol Dial Transpl 2007;22:2316-21.
    • (2007) Nephrol Dial Transpl , vol.22 , pp. 2316-2321
    • Diekmann, F.1    Gutierrez-Dalmau, A.2    Lopez, S.3
  • 47
    • 27644439969 scopus 로고    scopus 로고
    • Long-term results in renal transplant patients with allograft dysfunction after switching from calcineurin inhibitors to sirolimus
    • Bumbea V, Kamar N, Ribes D, et al. Long-term results in renal transplant patients with allograft dysfunction after switching from calcineurin inhibitors to sirolimus. Nephrol Dial Transplant 2005;20:2517-23.
    • (2005) Nephrol Dial Transplant , vol.20 , pp. 2517-2523
    • Bumbea, V.1    Kamar, N.2    Ribes, D.3
  • 48
    • 28544442713 scopus 로고    scopus 로고
    • Proteinuria following a switch from calcineurin inhibitors to sirolimus
    • Letavernier E, Pe'raldi MN, Pariente A, et al. Proteinuria following a switch from calcineurin inhibitors to sirolimus. Transplantation 2005;80:1198-203.
    • (2005) Transplantation , vol.80 , pp. 1198-1203
    • Letavernier, E.1    Pe'raldi, M.N.2    Pariente, A.3
  • 49
    • 6444233347 scopus 로고    scopus 로고
    • Sirolimus-based immunosuppression for liver transplantation in the presence of extended criteria for hepatocellular carcinoma
    • Kneteman NM, Oberholzer J, Al Saghier M, et al. Sirolimus-based immunosuppression for liver transplantation in the presence of extended criteria for hepatocellular carcinoma. Liver Transplantation 2004;10:1301-11.
    • (2004) Liver Transplantation , vol.10 , pp. 1301-1311
    • Kneteman, N.M.1    Oberholzer, J.2    Al Saghier, M.3
  • 50
    • 0037686693 scopus 로고    scopus 로고
    • Sirolimus as primary immunosuppression in liver transplantation is not associated with hepatic artery or wound complications
    • Dunkelberg JC, Trotter JF, Wachs M, et al. Sirolimus as primary immunosuppression in liver transplantation is not associated with hepatic artery or wound complications. Liver Transpl 2003;9:463-8.
    • (2003) Liver Transpl , vol.9 , pp. 463-468
    • Dunkelberg, J.C.1    Trotter, J.F.2    Wachs, M.3
  • 51
    • 0344613988 scopus 로고    scopus 로고
    • Blocking both signal 1 and signal 2 of T-cell activation prevents apoptosis of alloreactive T cells and induction of peripheral allograft tolerance
    • Li Y, Li XC, Zheng XX, et al. Blocking both signal 1 and signal 2 of T-cell activation prevents apoptosis of alloreactive T cells and induction of peripheral allograft tolerance. Nat Med 1999;5:1298- 302.
    • (1999) Nat Med , vol.5 , pp. 1298-1302
    • Li, Y.1    Li, X.C.2    Zheng, X.X.3
  • 52
    • 0345164351 scopus 로고    scopus 로고
    • Combined costimulation blockade plus rapamycin but not cyclosporine produces permanent engraftment
    • Li Y, Zheng XX, Li XC, et al. Combined costimulation blockade plus rapamycin but not cyclosporine produces permanent engraftment. Transplantation 1998;66:1387-8.
    • (1998) Transplantation , vol.66 , pp. 1387-1388
    • Li, Y.1    Zheng, X.X.2    Li, X.C.3
  • 54
    • 45549098562 scopus 로고    scopus 로고
    • T cell receptor signaling controls Foxp3 expression via PI3K, Akt, and mTOR
    • Sauer S, Bruno L, Hertweck A, et al. T cell receptor signaling controls Foxp3 expression via PI3K, Akt, and mTOR. Proc Natl Acad Sci U S A 2008;105:7797-802.
    • (2008) Proc Natl Acad Sci U S A , vol.105 , pp. 7797-7802
    • Sauer, S.1    Bruno, L.2    Hertweck, A.3
  • 56
  • 57
    • 0037182139 scopus 로고    scopus 로고
    • Rapamycin blocks tumor progression: Unlinking immunosuppression from antitumor efficacy
    • Luan FL, Hojo M, Maluccio M, et al. Rapamycin blocks tumor progression: unlinking immunosuppression from antitumor efficacy. Transplantation 2002;73:1565-72.
    • (2002) Transplantation , vol.73 , pp. 1565-1572
    • Luan, F.L.1    Hojo, M.2    Maluccio, M.3
  • 58
    • 34347220473 scopus 로고    scopus 로고
    • Defining the role of mTOR in cancer
    • Guertin DA, Sabatini DM. Defining the role of mTOR in cancer. Cancer Cell 2007;12:9-22.
    • (2007) Cancer Cell , vol.12 , pp. 9-22
    • Guertin, D.A.1    Sabatini, D.M.2
  • 59
    • 36048963331 scopus 로고    scopus 로고
    • Activation of the PTEN/ mTOR/STAT3 pathway in breast cancer stem-like cells is required for viability and maintenance
    • Zhou J, Wulfkuhle J, Zhang H, et al. Activation of the PTEN/ mTOR/STAT3 pathway in breast cancer stem-like cells is required for viability and maintenance. Proc Natl Acad Sci U S A 2007;104: 16158-63.
    • (2007) Proc Natl Acad Sci U S A , vol.104 , pp. 16158-16163
    • Zhou, J.1    Wulfkuhle, J.2    Zhang, H.3
  • 60
    • 34249779568 scopus 로고    scopus 로고
    • Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma
    • Hudes G, Carducci M, Tomczak P, et al. Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma. N Engl J Med 2007;356:2271-81.
    • (2007) N Engl J Med , vol.356 , pp. 2271-2281
    • Hudes, G.1    Carducci, M.2    Tomczak, P.3
  • 61
    • 48649107474 scopus 로고    scopus 로고
    • Efficacy of everolimus in advanced renal cell carcinoma: A double-blind, randomised, placebo-controlled phase III trial
    • Motzer RJ, Escudier B, Oudard S, et al. Efficacy of everolimus in advanced renal cell carcinoma: a double-blind, randomised, placebo-controlled phase III trial. Lancet 2008;372:449-56.
    • (2008) Lancet , vol.372 , pp. 449-456
    • Motzer, R.J.1    Escudier, B.2    Oudard, S.3
  • 62
    • 34248327483 scopus 로고    scopus 로고
    • De novo sirolimus-based immunosuppression after liver transplantation for hepatocellular carcinoma: Long-term outcomes and side effects
    • Toso C, Meeberg GA, Bigam DL, et al. De novo sirolimus-based immunosuppression after liver transplantation for hepatocellular carcinoma: long-term outcomes and side effects. Transplantation 2007;83:1162-8.
    • (2007) Transplantation , vol.83 , pp. 1162-1168
    • Toso, C.1    Meeberg, G.A.2    Bigam, D.L.3
  • 63
    • 33750433893 scopus 로고    scopus 로고
    • Low-dose oral rapamycin treatment reduces fibrogenesis, improves liver function, and prolongs survival in rats with established liver cirrhosis
    • Neef M, Ledermann M, Saegesser H, et al. Low-dose oral rapamycin treatment reduces fibrogenesis, improves liver function, and prolongs survival in rats with established liver cirrhosis. J Hepatol 2006;45:786-96.
    • (2006) J Hepatol , vol.45 , pp. 786-796
    • Neef, M.1    Ledermann, M.2    Saegesser, H.3
  • 64
    • 35748950134 scopus 로고    scopus 로고
    • Impact of steroids on hepatitis C virus replication in vivo and in vitro
    • Henry SD, Metselaar HJ, Van Dijck J, et al. Impact of steroids on hepatitis C virus replication in vivo and in vitro. Ann N Y Acad Sci 2007;1110:439-47.
    • (2007) Ann N Y Acad Sci , vol.1110 , pp. 439-447
    • Henry, S.D.1    Metselaar, H.J.2    Van Dijck, J.3
  • 65
    • 35748938770 scopus 로고    scopus 로고
    • Influence of steroids on HCV recurrence after liver transplantation: A prospective study
    • Vivarelli M, Burra P, La Barba G, et al. Influence of steroids on HCV recurrence after liver transplantation: A prospective study. J Hepatol 2007;47:793-8.
    • (2007) J Hepatol , vol.47 , pp. 793-798
    • Vivarelli, M.1    Burra, P.2    La Barba, G.3
  • 66
    • 42149168448 scopus 로고    scopus 로고
    • Steroid avoidance in liver transplantation: Meta-analysis and meta-regression of randomized trials
    • Segev DL, Sozio SM, Shin EJ, et al. Steroid avoidance in liver transplantation: meta-analysis and meta-regression of randomized trials. Liver Transpl 2008;14:512-25.
    • (2008) Liver Transpl , vol.14 , pp. 512-525
    • Segev, D.L.1    Sozio, S.M.2    Shin, E.J.3
  • 67
    • 34547588360 scopus 로고    scopus 로고
    • Short-term induction therapy with anti-thymocyte globulin and delayed use of calcineurin inhibitors in orthotopic liver transplantation
    • Soliman T, Hetz H, Burghuber C, et al. Short-term induction therapy with anti-thymocyte globulin and delayed use of calcineurin inhibitors in orthotopic liver transplantation. Liver Transpl 2007;13:1039- 44.
    • (2007) Liver Transpl , vol.13 , pp. 1039-1044
    • Soliman, T.1    Hetz, H.2    Burghuber, C.3
  • 68
    • 34249083437 scopus 로고    scopus 로고
    • Serum sickness following rabbit antithymocyte-globulin induction in a liver transplant recipient: Case report and literature review
    • Lundquist AL, Chari RS, Wood JH, et al. Serum sickness following rabbit antithymocyte-globulin induction in a liver transplant recipient: case report and literature review. Liver Transpl 2007;13:647-50.
    • (2007) Liver Transpl , vol.13 , pp. 647-650
    • Lundquist, A.L.1    Chari, R.S.2    Wood, J.H.3
  • 71
    • 35748953121 scopus 로고    scopus 로고
    • Treatment of autoimmune disease with rabbit anti-T lymphocyte globulin: Clinical efficacy and potential mechanisms of action
    • Lytton SD, Denton CP, Nutzenberger AM. Treatment of autoimmune disease with rabbit anti-T lymphocyte globulin: clinical efficacy and potential mechanisms of action. Ann N Y Acad Sci 2007;1110:285-96.
    • (2007) Ann N Y Acad Sci , vol.1110 , pp. 285-296
    • Lytton, S.D.1    Denton, C.P.2    Nutzenberger, A.M.3
  • 72
    • 0036192366 scopus 로고    scopus 로고
    • Improved treatment response with basiliximab immunoprophylaxis after liver transplantation: Results from a double-blind randomized placebo-controlled trial
    • Neuhaus P, Clavien PA, Kittur D, et al. Improved treatment response with basiliximab immunoprophylaxis after liver transplantation: results from a double-blind randomized placebo-controlled trial. Liver Transpl 2002;8:132-42.
    • (2002) Liver Transpl , vol.8 , pp. 132-142
    • Neuhaus, P.1    Clavien, P.A.2    Kittur, D.3
  • 73
    • 2942726371 scopus 로고    scopus 로고
    • Interleukin-2 receptor antibody (basiliximab) for immunosuppressive induction therapy after liver transplantation: A protocol with early elimination of steroids and reduction of tacrolimus dosage
    • Liu CL, Fan ST, Lo CM, et al. Interleukin-2 receptor antibody (basiliximab) for immunosuppressive induction therapy after liver transplantation: a protocol with early elimination of steroids and reduction of tacrolimus dosage. Liver Transpl 2004;10:728-33.
    • (2004) Liver Transpl , vol.10 , pp. 728-733
    • Liu, C.L.1    Fan, S.T.2    Lo, C.M.3
  • 74
    • 33847678151 scopus 로고    scopus 로고
    • Anti-IL2 induction in liver transplantation with 93% rejection-free patient and graft survival at 18 months
    • Ramirez CB, Doria C, Di Francesco F, et al. Anti-IL2 induction in liver transplantation with 93% rejection-free patient and graft survival at 18 months. J Surg Res 2007;138:198-204.
    • (2007) J Surg Res , vol.138 , pp. 198-204
    • Ramirez, C.B.1    Doria, C.2    Di Francesco, F.3
  • 75
    • 0034719368 scopus 로고    scopus 로고
    • Experience with daclizumab in liver transplantation: Renal transplant dosing without calcineurin inhibitors is insufficient to prevent acute rejection in liver transplantation
    • Hirose R, Roberts JP, Quan D, et al. Experience with daclizumab in liver transplantation: renal transplant dosing without calcineurin inhibitors is insufficient to prevent acute rejection in liver transplantation. Transplantation 2000;69:307-11.
    • (2000) Transplantation , vol.69 , pp. 307-311
    • Hirose, R.1    Roberts, J.P.2    Quan, D.3
  • 76
    • 0036193103 scopus 로고    scopus 로고
    • Immunoprophylaxis with basiliximab, a chimeric anti-interleukin-2 receptor monoclonal antibody, in combination with azathioprine-containing triple therapy in liver transplant recipients
    • Calmus Y, Scheele JR, Gonzalez-Pinto I, et al. Immunoprophylaxis with basiliximab, a chimeric anti-interleukin-2 receptor monoclonal antibody, in combination with azathioprine-containing triple therapy in liver transplant recipients. Liver Transpl 2002;8:123-31.
    • (2002) Liver Transpl , vol.8 , pp. 123-131
    • Calmus, Y.1    Scheele, J.R.2    Gonzalez-Pinto, I.3
  • 77
    • 34248146578 scopus 로고    scopus 로고
    • + regulatory T cells detach from the graft and circulate in recipients after liver transplantation
    • + regulatory T cells detach from the graft and circulate in recipients after liver transplantation. J Immunol 2007;178:6066-72.
    • (2007) J Immunol , vol.178 , pp. 6066-6072
    • Demirkiran, A.1    Bosma, B.M.2    Kok, A.3
  • 79
    • 33845406639 scopus 로고    scopus 로고
    • Anti-CD25 mAB administration prevents spontaneous liver transplant tolerance
    • Li W, Carper K, Liang Y, et al. Anti-CD25 mAB administration prevents spontaneous liver transplant tolerance. Transplant Proc 2006;38:3207-8.
    • (2006) Transplant Proc , vol.38 , pp. 3207-3208
    • Li, W.1    Carper, K.2    Liang, Y.3
  • 80
    • 0021227678 scopus 로고
    • Elimination of graft-versus-host disease by in-vitro depletion of alloreactive lymphocytes with a monoclonal rat anti-human lymphocyte antibody (CAMPATH-1)
    • Waldmann H, Polliak A, Hale G, et al. Elimination of graft-versus-host disease by in-vitro depletion of alloreactive lymphocytes with a monoclonal rat anti-human lymphocyte antibody (CAMPATH-1). Lancet 1984;2:483-6.
    • (1984) Lancet , vol.2 , pp. 483-486
    • Waldmann, H.1    Polliak, A.2    Hale, G.3
  • 81
    • 33746921599 scopus 로고    scopus 로고
    • The evolving role of alemtuzumab (Campath-1H) for immunosuppressive therapy in organ transplantation
    • Magliocca JF, Knechtle SJ. The evolving role of alemtuzumab (Campath-1H) for immunosuppressive therapy in organ transplantation. Transpl Int 2006;19:705-14.
    • (2006) Transpl Int , vol.19 , pp. 705-714
    • Magliocca, J.F.1    Knechtle, S.J.2
  • 82
    • 20544458513 scopus 로고    scopus 로고
    • Alemtuzumab (CAMPATH 1H) induction therapy in cadaveric kidney transplantation - efficacy and safety at five years
    • Watson CJ, Bradley JA, Friend PJ, et al. Alemtuzumab (CAMPATH 1H) induction therapy in cadaveric kidney transplantation - efficacy and safety at five years. Am J Transplant 2005;5:1347-53.
    • (2005) Am J Transplant , vol.5 , pp. 1347-1353
    • Watson, C.J.1    Bradley, J.A.2    Friend, P.J.3
  • 83
    • 47249132479 scopus 로고    scopus 로고
    • Calcineurin inhibitor withdrawal after renal transplantation with alemtuzumab: Clinical outcomes and effect on T-regulatory cells
    • Pascual J, Bloom D, Torrealba J, et al. Calcineurin inhibitor withdrawal after renal transplantation with alemtuzumab: clinical outcomes and effect on T-regulatory cells. Am J Transplant 2008;8:1529-36.
    • (2008) Am J Transplant , vol.8 , pp. 1529-1536
    • Pascual, J.1    Bloom, D.2    Torrealba, J.3
  • 84
    • 33749444584 scopus 로고    scopus 로고
    • Outcomes at 3 years of a prospective pilot study of Campath-1H and sirolimus immunosuppression for renal transplantation
    • Barth RN, Janus CA, Lillesand CA, et al. Outcomes at 3 years of a prospective pilot study of Campath-1H and sirolimus immunosuppression for renal transplantation. Transpl Int 2006;19:885-92.
    • (2006) Transpl Int , vol.19 , pp. 885-892
    • Barth, R.N.1    Janus, C.A.2    Lillesand, C.A.3
  • 85
    • 40449101381 scopus 로고    scopus 로고
    • + regulatory T cells increase de novo in kidney transplant patients after immunodepletion with Campath-1H
    • + regulatory T cells increase de novo in kidney transplant patients after immunodepletion with Campath-1H. Am J Transplant 2008;8:793-802.
    • (2008) Am J Transplant , vol.8 , pp. 793-802
    • Bloom, D.D.1    Chang, Z.2    Fechner, J.H.3
  • 86
    • 2342582720 scopus 로고    scopus 로고
    • Preliminary experience with alemtuzumab (Campath-1H) and low-dose tacrolimus immunosuppression in adult liver transplantation
    • Tzakis AG, Tryphonopoulos P, Kato T, et al. Preliminary experience with alemtuzumab (Campath-1H) and low-dose tacrolimus immunosuppression in adult liver transplantation. Transplantation 2004;77:1209-14.
    • (2004) Transplantation , vol.77 , pp. 1209-1214
    • Tzakis, A.G.1    Tryphonopoulos, P.2    Kato, T.3
  • 87
    • 6344256213 scopus 로고    scopus 로고
    • Use of alemtuzumab and tacrolimus monotherapy for cadaveric liver transplantation: With particular reference to hepatitis C virus
    • Marcos A, Eghtesad B, Fung JJ, et al. Use of alemtuzumab and tacrolimus monotherapy for cadaveric liver transplantation: with particular reference to hepatitis C virus. Transplantation 2004;78:966-71.
    • (2004) Transplantation , vol.78 , pp. 966-971
    • Marcos, A.1    Eghtesad, B.2    Fung, J.J.3
  • 88
    • 61649095158 scopus 로고    scopus 로고
    • Six year experience with Campath-1H (C1H) induction in adult liver transplantation
    • Tryphonopoulos P, Weppler D, Nishida S, et al. Six year experience with Campath-1H (C1H) induction in adult liver transplantation. Am J Transplant 2008;8(suppl 2):307.
    • (2008) Am J Transplant , vol.8 , Issue.SUPPL. 2 , pp. 307
    • Tryphonopoulos, P.1    Weppler, D.2    Nishida, S.3
  • 89
    • 23944502334 scopus 로고    scopus 로고
    • Costimulation blockade with belatacept in renal transplantation
    • Vincenti F, Larsen C, Durrbach A, et al. Costimulation blockade with belatacept in renal transplantation. New EnglJ Med 2005;353:770-81.
    • (2005) New EnglJ Med , vol.353 , pp. 770-781
    • Vincenti, F.1    Larsen, C.2    Durrbach, A.3
  • 91
    • 9144272645 scopus 로고    scopus 로고
    • Combinations of anti-LFA-1, everolimus, anti-CD40 ligand, and allogeneic bone marrow induce central transplantation tolerance through hemopoietic chimerism, including protection from chronic heart allograft rejection
    • Metzler B, Gfeller P, Bigaud M, et al. Combinations of anti-LFA-1, everolimus, anti-CD40 ligand, and allogeneic bone marrow induce central transplantation tolerance through hemopoietic chimerism, including protection from chronic heart allograft rejection. J Immunol 2004;173:7025-36.
    • (2004) J Immunol , vol.173 , pp. 7025-7036
    • Metzler, B.1    Gfeller, P.2    Bigaud, M.3
  • 92
    • 12744274512 scopus 로고    scopus 로고
    • Indefinite survival of neonatal porcine islet xenografts by simultaneous targeting of LFA-1 and CD154 or CD45RB
    • Rayat GR, Gill RG. Indefinite survival of neonatal porcine islet xenografts by simultaneous targeting of LFA-1 and CD154 or CD45RB. Diabetes 2005;54:443-51.
    • (2005) Diabetes , vol.54 , pp. 443-451
    • Rayat, G.R.1    Gill, R.G.2
  • 93
    • 34250202520 scopus 로고    scopus 로고
    • A phase I/II randomized open-label multicenter trial of efalizumab, a humanized anti-CD11a, anti-LFA-1 in renal transplantation
    • Vincenti F, Mendez R, Pescovitz M, et al. A phase I/II randomized open-label multicenter trial of efalizumab, a humanized anti-CD11a, anti-LFA-1 in renal transplantation. Am J Transplant 2007;7:1770- 7.
    • (2007) Am J Transplant , vol.7 , pp. 1770-1777
    • Vincenti, F.1    Mendez, R.2    Pescovitz, M.3
  • 94
    • 33745063675 scopus 로고    scopus 로고
    • Regulatory dendritic cell therapy in organ transplantation
    • McCurry KR, Colvin BL, Zahorchak AF, et al. Regulatory dendritic cell therapy in organ transplantation. Transpl Int 2006;19:525-38.
    • (2006) Transpl Int , vol.19 , pp. 525-538
    • McCurry, K.R.1    Colvin, B.L.2    Zahorchak, A.F.3
  • 95
    • 40449104477 scopus 로고    scopus 로고
    • Macrophages driven to a novel state of activation have anti-inflammatory properties in mice
    • Brem-Exner BG, Sattler C, Hutchinson JA, et al. Macrophages driven to a novel state of activation have anti-inflammatory properties in mice. J Immunol 2008;180:335-49.
    • (2008) J Immunol , vol.180 , pp. 335-349
    • Brem-Exner, B.G.1    Sattler, C.2    Hutchinson, J.A.3
  • 96
    • 33845491455 scopus 로고    scopus 로고
    • Only the CD45RA+ subpopulation of CD4+CD25high T cells gives rise to homogeneous regulatory T-cell lines upon in vitro expansion
    • Hoffmann P, Eder R, Boeld TJ, et al. Only the CD45RA+ subpopulation of CD4+CD25high T cells gives rise to homogeneous regulatory T-cell lines upon in vitro expansion. Blood 2006;108:4260-7.
    • (2006) Blood , vol.108 , pp. 4260-4267
    • Hoffmann, P.1    Eder, R.2    Boeld, T.J.3
  • 97
    • 53549133080 scopus 로고    scopus 로고
    • Transplant acceptance-inducing cells as an immune-conditioning therapy in renal transplantation
    • Hutchinson JA, Riquelme P, Brem-Exner BG, et al. Transplant acceptance-inducing cells as an immune-conditioning therapy in renal transplantation. Transpl Int 2008;21:728-41.
    • (2008) Transpl Int , vol.21 , pp. 728-741
    • Hutchinson, J.A.1    Riquelme, P.2    Brem-Exner, B.G.3
  • 98
    • 53549101269 scopus 로고    scopus 로고
    • A cell-based approach to the minimization of immunosuppression in renal transplantation
    • Hutchinson JA, Brem-Exner BG, Riquelme P, et al. A cell-based approach to the minimization of immunosuppression in renal transplantation. Transpl Int 2008;21:742-54.
    • (2008) Transpl Int , vol.21 , pp. 742-754
    • Hutchinson, J.A.1    Brem-Exner, B.G.2    Riquelme, P.3
  • 99
    • 58149204330 scopus 로고    scopus 로고
    • Preoperative treatment of a presensitized kidney transplant recipient with donor-derived transplant acceptance-inducing cells
    • Hutchinson JA, Roelen D, Riquelme P, et al. Preoperative treatment of a presensitized kidney transplant recipient with donor-derived transplant acceptance-inducing cells. Transpl Int 2008;21:808-13.
    • (2008) Transpl Int , vol.21 , pp. 808-813
    • Hutchinson, J.A.1    Roelen, D.2    Riquelme, P.3
  • 100
    • 0030899508 scopus 로고    scopus 로고
    • Weaning of immunosuppression in liver transplant recipients
    • Mazariegos GV, Reyes J, Marino IR, et al. Weaning of immunosuppression in liver transplant recipients. Transplantation 1997;63:243-9.
    • (1997) Transplantation , vol.63 , pp. 243-249
    • Mazariegos, G.V.1    Reyes, J.2    Marino, I.R.3
  • 101
    • 20344366308 scopus 로고    scopus 로고
    • Long-term outcome of immunosuppression withdrawal after liver transplantation
    • Girlanda R, Rela M, Williams R, et al. Long-term outcome of immunosuppression withdrawal after liver transplantation. Transplant Proc 2005;37:1708-9.
    • (2005) Transplant Proc , vol.37 , pp. 1708-1709
    • Girlanda, R.1    Rela, M.2    Williams, R.3
  • 102
    • 0035881424 scopus 로고    scopus 로고
    • Weaning of immunosuppression in living donor liver transplant recipients
    • Takatsuki M, Uemoto S, Inomata Y, et al. Weaning of immunosuppression in living donor liver transplant recipients. Transplantation 2001;72:449-54.
    • (2001) Transplantation , vol.72 , pp. 449-454
    • Takatsuki, M.1    Uemoto, S.2    Inomata, Y.3
  • 103
    • 10044262162 scopus 로고    scopus 로고
    • Analyses of peripheral blood mononuclear cells in operational tolerance after pediatric living donor liver transplantation
    • Li Y, Koshiba T, Yoshizawa A, et al. Analyses of peripheral blood mononuclear cells in operational tolerance after pediatric living donor liver transplantation. Am J Transplant 2004;4:2118-25.
    • (2004) Am J Transplant , vol.4 , pp. 2118-2125
    • Li, Y.1    Koshiba, T.2    Yoshizawa, A.3
  • 104
  • 105
    • 48749084927 scopus 로고    scopus 로고
    • Using transcriptional profiling to develop a diagnostic test of operational tolerance in liver transplant recipients
    • Martinez-Llordella M, Lozano JJ, Puig-Pey I, et al. Using transcriptional profiling to develop a diagnostic test of operational tolerance in liver transplant recipients. J Clin Invest 2008;118:2845-57.
    • (2008) J Clin Invest , vol.118 , pp. 2845-2857
    • Martinez-Llordella, M.1    Lozano, J.J.2    Puig-Pey, I.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.